Loading
₹2.44
−7.58%BSE close, 16 Nov 2026
−30.48%
TRANSGENE BIOTEK is a small cap company in the Healthcare sector, listed on BSE under the symbol TRABI (BSE code 526139). At ₹2.44 a share, the market values the whole company at ₹16 crore.
Over the past year the share price has fallen 28.0%, and it is 41.8% below its 52-week high.
Companies of a similar size in the same sector include Shree Ganesh Biotech (India) L, CENTUPLE GLOBAL, ZENITH HEALTH CARE and COLINZ LABORATORIES.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| TRANSGENE BIOTEK | ₹2.44 | ₹16 cr | n/a | n/a | n/a | −28.02% |
| Shree Ganesh Biotech (India) L | ₹0.45 | ₹18 cr | n/a | n/a | n/a | −38.36% |
| CENTUPLE GLOBAL | ₹32.62 | ₹18 cr | n/a | n/a | n/a | −54.94% |
| ZENITH HEALTH CARE | ₹3.20 | ₹17 cr | n/a | n/a | n/a | −17.10% |
| COLINZ LABORATORIES | ₹67.50 | ₹17 cr | n/a | n/a |
| n/a |
| +69.56% |
| LOOKS HEALTH SERVICES | ₹14.15 | ₹15 cr | n/a | n/a | n/a | +182.44% |
|---|
| GENOMIC VALLEY BIOTECH | ₹47.00 | ₹14 cr | n/a | n/a | n/a | +51.56% |
|---|
| VENMAX DRUGS AND PHARMACEUTICA | ₹12.36 | ₹14 cr | n/a | n/a | n/a | −55.60% |
|---|
| Global Longlife Hospital and R | ₹13.53 | ₹14 cr | n/a | n/a | n/a | −42.96% |
|---|